BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36427970)

  • 1. Prenatal diagnosis and molecular cytogenetic characterization of a de novo deletion of 4q34.1→qter associated with low PAPP-A and low PlGF in the first-trimester maternal serum screening, congenital heart defect on fetal ultrasound and a false negative non-invasive prenatal testing (NIPT) result.
    Chen CP; Chen SW; Wang LK; Chern SR; Wu PS; Wu FT; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2022 Nov; 61(6):1039-1043. PubMed ID: 36427970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of maternal uniparental disomy 9 in association with low-level mosaic trisomy 9 at amniocentesis in a pregnancy associated with intrauterine growth restriction, abnormal first-trimester screening result (low PAPP-A and low PlGF), maternal preeclampsia and a favorable outcome.
    Chen CP; Chern SR; Wu PS; Chen SW; Wu FT; Chen LF; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):141-145. PubMed ID: 35181026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis of mosaic trisomy 16 by amniocentesis in a pregnancy associated with abnormal first-trimester screening result (low PAPP-A and low PlGF), intrauterine growth restriction and a favorable outcome.
    Chen CP; Lan FH; Chern SR; Wu PS; Chen SW; Wu FT; Lee CC; Lee MS; Pan CW; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1107-1111. PubMed ID: 34794747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis and molecular cytogenetic characterization of mosaic ring chromosome 21 associated with low PAPP-A and low PlGF in the first-trimester maternal serum screening.
    Chen CP; Wang LK; Chern SR; Wu PS; Chen SW; Wu FT; Lee CC; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):359-363. PubMed ID: 35361402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level mosaic trisomy 9 at amniocentesis associated with a positive non-invasive prenatal testing for trisomy 9, maternal uniparental disomy 9, intrauterine growth restriction and a favorable fetal outcome in a pregnancy.
    Chen CP; Ko TM; Chen SW; Chern SR; Wu FT; Pan YT; Pan CW; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2023 May; 62(3):457-460. PubMed ID: 37188454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of partial monosomy 2q (2q37.3→qter) and partial trisomy 10q (10q24.31→qter) of paternal origin associated with increased nuchal translucency and abnormal maternal serum screening results.
    Chen CP; Liou JD; Seow KM; Chern SR; Wu PS; Chen SW; Wu FT; Town DD; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):758-762. PubMed ID: 32917332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic characterization of de novo concomitant distal 8p deletion of 8p23.3p23.1 and Xp and Xq deletion of Xp22.13q28 due to an unbalanced X;8 translocation detected by amniocentesis.
    Chen CP; Hung FY; Chen SW; Wu FT; Pan YT; Wu PS; Chern SR; Lee CC; Lee MS; Wang W
    Taiwan J Obstet Gynecol; 2023 Jan; 62(1):128-131. PubMed ID: 36720525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic characterization of del(X)(p22.33)mat and de novo dup(4)(q34.3q35.2) in a male fetus with multiple anomalies of facial dysmorphism, ventriculomegaly, congenital heart defects, short long bones and clinodactyly.
    Chen CP; Huang JP; Chen YY; Chen SW; Chern SR; Wu PS; Wu FT; Pan YT; Chen WL; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2023 May; 62(3):453-456. PubMed ID: 37188453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic trisomy 16 at amniocentesis in a pregnancy associated with positive non-invasive prenatal testing for trisomy 16, placental trisomy 16, intrauterine growth restriction, intrauterine fetal death, cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, and prenatal progressive decrease of the aneuploid cell line.
    Chen CP; Wu FT; Chen YY; Pan YT; Wu PS; Lee MS; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2023 Jul; 62(4):597-601. PubMed ID: 37407203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level mosaic trisomy 14 at amniocentesis in a pregnancy associated with congenital heart defects and intrauterine growth restriction on fetal ultrasound.
    Chen CP; Wu FT; Wang LK; Pan YT; Lee MS; Wang W
    Taiwan J Obstet Gynecol; 2023 Jul; 62(4):594-596. PubMed ID: 37407202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level mosaic trisomy 21 at amniocentesis in a pregnancy associated with a negative NIPT result, cytogenetic discrepancy in various tissues, perinatal progressive decrease of the aneuploid cell line and a favorable fetal outcome.
    Chen CP; Hsu TY; Chern SR; Wu PS; Wu FT; Pan YT; Lee CC; Chen WL; Wang W
    Taiwan J Obstet Gynecol; 2023 Jul; 62(4):582-585. PubMed ID: 37407199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of maternal uniparental disomy 16 associated with mosaic trisomy 16 at amniocentesis, and pericardial effusion and intrauterine growth restriction in the fetus.
    Chen CP; Ko TM; Chern SR; Wu PS; Chen SW; Wu FT; Chen YY; Town DD; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2021 May; 60(3):534-539. PubMed ID: 33966743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of paternal origin of fetal de novo rea(21q;21q) down syndrome in a pregnancy of a young woman associated with an abnormal first-trimester maternal serum screening result.
    Chen CP; Jou QB; Chern SR; Chen SW; Wu FT; Chen WL; Wang W
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):356-358. PubMed ID: 35361401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of de novo del(18)(q22.2) and a familial of 15q13.2-q13.3 microduplication in a fetus with congenital heart defects.
    Chen CP; Chen CY; Chern SR; Wu PS; Chen SW; Wu FT; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):704-708. PubMed ID: 31542097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of pseudomosaicism for trisomy 20 at amniocentesis with a negative non-invasive prenatal testing (NIPT) result in a pregnancy with a favorable outcome.
    Chen CP; Wang LK; Chern SR; Wu PS; Chen SW; Wu FT; Chen YY; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2022 Jul; 61(4):675-676. PubMed ID: 35779920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis and molecular cytogenetic characterization of a de novo 3.19-Mb chromosome 14q32.13-q32.2 deletion of paternal origin.
    Chen CP; Wang LK; Chern SR; Wu PS; Chen SW; Wu FT; Chen YY; Chen WL; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):766-769. PubMed ID: 32917334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis and molecular cytogenetic characterization of de novo partial monosomy 3p (3p26.3→pter) and partial trisomy 16q (16q23.1→qter).
    Chen CP; Hung FY; Chern SR; Wu PS; Chen YN; Chen SW; Lee CC; Wang W
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):288-92. PubMed ID: 27125417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis and molecular genetic analysis of recurrent trisomy 18 of maternal origin in two consecutive pregnancies.
    Chen CP; Wu FT; Wong CH; Chen SW; Chern SR; Pan YT; Chen WL; Wang W
    Taiwan J Obstet Gynecol; 2023 May; 62(3):444-447. PubMed ID: 37188451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.